Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
538.5 USD | +6.14% | +3.27% | +14.19% |
Financials (USD)
Sales 2024 * | 171B | Sales 2025 * | 182B | Capitalization | 125B |
---|---|---|---|---|---|
Net income 2024 * | 8.04B | Net income 2025 * | 9.09B | EV / Sales 2024 * | 0.83 x |
Net Debt 2024 * | 17.34B | Net Debt 2025 * | 13.7B | EV / Sales 2025 * | 0.76 x |
P/E ratio 2024 * |
15.6
x | P/E ratio 2025 * |
13.6
x | Employees | 104,900 |
Yield 2024 * |
1.17% | Yield 2025 * |
1.27% | Free-Float | 99.6% |
Latest transcript on Elevance Health, Inc.
1 day | +6.14% | ||
1 week | -1.00% | ||
Current month | +1.87% | ||
1 month | +1.87% | ||
3 months | +7.89% | ||
6 months | +12.30% | ||
Current year | +14.19% |
Managers | Title | Age | Since |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 23-09-05 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | Feb. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 13-09-30 | |
Director/Board Member | 55 | 22-10-31 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.22% | 17 M€ | +6.09% | - | |
2.36% | 1,085 M€ | +9.05% | - | |
2.07% | 8 M€ | +3.41% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 538.5 | +6.14% | 4,148,681 |
24-05-30 | 507.3 | +0.36% | 1,016,074 |
24-05-29 | 505.5 | -2.63% | 1,412,390 |
24-05-28 | 519.2 | -0.43% | 1,522,033 |
24-05-24 | 521.4 | -4.14% | 1,533,777 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.19% | 118B | |
-5.91% | 443B | |
+15.08% | 94.03B | |
-21.78% | 41.86B | |
-3.53% | 36.8B | |
-12.93% | 17.93B | |
-27.51% | 2.53B | |
-8.59% | 1.51B |
- Stock Market
- Equities
- ELV Stock